Hermes Biosciences

Hermes Biosciences develops automated technology that isolates and analyzes intact EVs from biological samples. Co-founded by Prof. Utkan Demirci and General Inception, the technology delivers nearly 100 times more vesicles than ultracentrifugation and 10 times more than other commercially available systems while preserving vesicle integrity and molecular cargo. The platform provides high-quality exosome data for research, diagnostic development and clinical innovation to support new ways to detect, understand and treat disease.